.png){kind=logo}
CAN Clinical Trials
We run ground-breaking clinical trials across the developmental lifespan.
Our goal is to quickly and efficiently find answers and interventions that offer real solutions and support to individuals and families.
Transcranial magnetic stimulation (TMS) to support social communication
Our team is partnering with clinicians and researchers from around Australia to investigate whether transcranial magnetic stimulation (TMS) is a safe and effective method to help support social communication in autistic adolescents and adults .
This trial has closed for recruitment.
Supporting social learning therapy in autistic pre-schoolers
As part of our ground-breaking oxytocin research, this study is investigating the effectiveness of a new nasal spray in reducing social and behavioural challenges in autistic children when combined with social learning therapy.
This trial has closed for recruitment.
Investigating a new treatment to support mood and behaviour in autistic adolescents
Between 40–70% of autistic individuals experience persistent gastrointestinal (GI) symptoms. These symptoms may correlate with gut microbiome imbalances, bacterial metabolite levels, and increased behavioural challenges.
The clinical research team worked with Axial and three other sites on a Phase 1b/2a trial to assess the safety, tolerability and efficacy of a pharmaceutical therapy called AB-2004.
Investigating a new treatment to support autistic adolescents and adults with social communication
In the IRIS study, we are looking to find outwhether the investigational study drug,designated ML-004, will help alleviate some ofthe challenges that can impact communicationin those on the autism spectrum.
This trial is currently recruiting.
